CN Patent
CN101262847A — 包含嘧啶-磺酰胺的稳定性医药组合物
Assigned to Actelion Pharmaceuticals Ltd · Expires 2008-09-10 · 18y expired
What this patent protects
本发明关于稳定性医药组合物,其包含下式的化合物或其医药学上可接受的盐、溶剂合物、水合物或其形态形式。
USPTO Abstract
本发明关于稳定性医药组合物,其包含下式的化合物或其医药学上可接受的盐、溶剂合物、水合物或其形态形式。
Drugs covered by this patent
- Opsumit (MACITENTAN) · AstraZeneca
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.